Bellevue Life Sciences Acquisition (BLAC) Stock Chart & Stock Price History $0.52 +0.04 (+9.09%) As of 08/22/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Bellevue Life Sciences Acquisition Stock Price Performance The Bellevue Life Sciences Acquisition (BLAC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 95.23%, with a year-to-date return of -95.53%. In the past month, the stock has decreased 49.51%, reflecting recent market activity. As of the latest close, Bellevue Life Sciences Acquisition traded at $0.50 with a market cap of $2.03 million and volume of 240,714 shares. Receive BLAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.74%1 Month Performance-49.51%3 Month Performance-57.44%Year-To-Date Performance-95.53%1 Year Performance-95.23% BLAC Stock Chart for Sunday, August, 24, 2025 BLAC Chart by TradingView Bellevue Life Sciences Acquisition Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.50$0.50$0.55$0.48240,714 shs$2.03 million08/21/2025$0.53$0.50-5.45%$0.55$0.48240,714 shs$2.03 million08/20/2025$0.53$0.53+0.15%$0.56$0.51145,907 shs$2.14 million08/19/2025$0.53$0.53$0.54$0.5268,941 shs$2.14 million08/18/2025$0.53$0.53$0.54$0.5268,941 shs$2.14 million08/15/2025$0.56$0.56$0.59$0.56114,310 shs$2.27 million08/14/2025$0.60$0.56-7.09%$0.59$0.56114,310 shs$12.16 million08/13/2025$0.60$0.60$0.64$0.5977,807 shs$2.44 million08/12/2025$0.60$0.60$0.64$0.5977,807 shs$2.44 million08/11/2025$0.60$0.60$0.64$0.5977,807 shs$2.44 million Get the Latest News and Ratings for BLAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$0.66$0.62-5.50%$0.65$0.60217,280 shs$2.50 million08/07/2025$0.66$0.66$0.67$0.62159,749 shs$2.65 million08/06/2025$0.66$0.66$0.67$0.62159,749 shs$2.65 million08/05/2025$0.64$0.66+1.98%$0.67$0.62159,749 shs$2.65 million08/04/2025$0.64$0.64$0.73$0.62400,443 shs$2.60 million08/01/2025$0.87$0.69-20.44%$0.80$0.651.26 million shs$2.78 million07/31/2025$0.94$0.87-8.32%$0.97$0.836.94 million shs$3.50 million07/30/2025$0.94$0.94$1.04$0.91387,491 shs$3.81 million07/29/2025$0.98$0.94-3.72%$1.04$0.91387,491 shs$3.81 million07/28/2025$0.98$0.98$1.06$0.90756,392 shs$3.96 million07/25/2025$1.02$1.02$1.05$1.0274,052 shs$4.12 million07/24/2025$1.06$1.02-3.77%$1.05$1.0274,052 shs$4.12 million07/23/2025$1.06$1.06$1.07$1.01325,374 shs$4.28 million Related Companies LUCY Stock Chart CODX Stock Chart SINT Stock Chart ICU Stock Chart LFWD Stock Chart HSCS Stock Chart PAVM Stock Chart POAI Stock Chart SSKN Stock Chart STRR Stock Chart Receive BLAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BLAC) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Life Sciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access